These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16475970)

  • 21. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective.
    Zhao H
    Drug Discov Today; 2007 Feb; 12(3-4):149-55. PubMed ID: 17275735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.
    Inglese J; Auld DS; Jadhav A; Johnson RL; Simeonov A; Yasgar A; Zheng W; Austin CP
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11473-8. PubMed ID: 16864780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragment library design: using cheminformatics and expert chemists to fill gaps in existing fragment libraries.
    Kutchukian PS; So SS; Fischer C; Waller CL
    Methods Mol Biol; 2015; 1289():43-53. PubMed ID: 25709032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hit-directed nearest-neighbor searching.
    Shanmugasundaram V; Maggiora GM; Lajiness MS
    J Med Chem; 2005 Jan; 48(1):240-8. PubMed ID: 15634017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which aspects of HTS are empirically correlated with downstream success?
    Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The essential roles of chemistry in high-throughput screening triage.
    Dahlin JL; Walters MA
    Future Med Chem; 2014 Jul; 6(11):1265-90. PubMed ID: 25163000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-based medicinal chemistry optimization of high throughput screening hits for orally active antimalarials. Part 2: hits from SoftFocus kinase and other libraries.
    Younis Y; Street LJ; Waterson D; Witty MJ; Chibale K
    J Med Chem; 2013 Oct; 56(20):7750-4. PubMed ID: 23927599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Learning from the data: mining of large high-throughput screening databases.
    Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
    J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-stoichiometric inhibition in integrated lead finding - a literature review.
    Klumpp M
    Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput development of amphiphile self-assembly materials: fast-tracking synthesis, characterization, formulation, application, and understanding.
    Mulet X; Conn CE; Fong C; Kennedy DF; Moghaddam MJ; Drummond CJ
    Acc Chem Res; 2013 Jul; 46(7):1497-505. PubMed ID: 23427836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysing the output from primary screening.
    Nowlin D; Bingham P; Berridge A; Gribbon P; Laflin P; Sewing A
    Comb Chem High Throughput Screen; 2006 Jun; 9(5):331-7. PubMed ID: 16787146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Project-focused activity and knowledge tracker: a unified data analysis, collaboration, and workflow tool for medicinal chemistry project teams.
    Brodney MD; Brosius AD; Gregory T; Heck SD; Klug-McLeod JL; Poss CS
    J Chem Inf Model; 2009 Dec; 49(12):2639-49. PubMed ID: 19899777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lead-oriented synthesis: a new opportunity for synthetic chemistry.
    Nadin A; Hattotuwagama C; Churcher I
    Angew Chem Int Ed Engl; 2012 Jan; 51(5):1114-22. PubMed ID: 22271624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of high throughput technology for the screening of natural products.
    Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
    Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
    Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
    J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.